Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss…
PMV Pharma announces proposed public offering (PMVP:NASDAQ)
PMV Pharmaceuticals () said on Monday it launched an underwritten public offering of common stock and accompanying warrants. The company may also offer pre-funded warrants to certain investors in lieu of common stock, along with accompanying…
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs (NYSEARCA:XLV)
Nine of the 16 Big Pharma stocks covered in this article set new 52-week highs during August, reflecting strong momentum across the sector. Also, the rally has been driven by strong Q2 results, as well as Wall Street's growing shift toward…
India calls for more predictable regulatory environment in Brazil to boost pharma exports
India has called for a more predictable regulatory environment in Brazil to boost exports of pharmaceutical goods, the Commerce Ministry said on Monday (August 31, 2026). The issue came up for discussion during the eighth meeting of the…
China shows way in new pharma race: Own meds, don't just make 'em
Pharmaceutical geopolitics is usually mapped through factories. China's vast pharmaceutical supply chain, India's strength in low-cost generics and the concentration of patented drug discovery in richer economies have shaped that discussion for…
Jim Cramer Calls The Data Center Trade Dead, Pivots To Software And Pharma In Bold Market Rotation Call
On CNBC's Squawk on the Street, Jim Cramer declared that investor appetite has decisively turned against the trade that powered markets for much of the past year. “We're defaulting to all right, give me anything but tech, give me anything…
Ascendis Pharma A/S (NASDAQ:ASND) Trading Up 7.3% - Here's Why
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) rose 7.3% during trading on Monday. The company traded as high as $266.17 and last traded at $266.06. Approximately 172,528 shares changed hands during trading, a decline of 74% from the…
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 6% - Should You Sell?
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) fell 6% on Monday. The stock traded as low as $17.19 and last traded at $17.1850. 2,433 shares traded hands during mid-day trading, a decline of 64%…
Headlands Technologies LLC Invests $5.09 Million in Royalty Pharma PLC $RPRX
Headlands Technologies LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 90,729 shares of the biopharmaceutical…
Short Interest in OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Declines By 38.4%
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) saw a significant decline in short interest during the month of August. As of August 14th, there was short interest totaling 83,450 shares, a decline of 38.4% from the July 30th…
The big losers in the markets today
Among the 30 Sensex firms, Adani Ports fell the most by 4.11 per cent. Index major HDFC Bank reversed early gains to close down by 1.53 per cent as its CEO and Managing Director Sashidhar Jagdishan announced that he will opt for reappointment after…
Bank of America Has Lowered Expectations for Ascendis Pharma A/S (NASDAQ:ASND) Stock Price
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price objective dropped by analysts at Bank of America from $306.00 to $304.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a 'buy' rating on the…
The Latest: Trump oil deal raises questions, Vance and Bessent seek to reassure allies
Venezuelans are expressing outrage and the oil industry is waiting for details on President Donald Trump's announcement that Venezuela 's acting president has agreed to give an unnamed U.S. company control of vast amounts of the South American…
Indian Stock Market Declines Amid West Asia Tensions, Rising Crude Oil Prices
Indian stock markets experienced a decline, with the Sensex and Nifty closing lower, as renewed tensions in West Asia pushed crude oil prices higher, sparking concerns over inflation and potential interest rate hikes. Indian stock markets…
Receive a Daily briefing on Pharma Industry News
Get Started